Repart® Supreme Intradermal Implant

Compliant with TU 32.50.22-012-29155953-2019, available in three variants: Soft, Medium, and Hard.

Repart® Supreme Soft

Intradermal implant, 1.0 ml volume, 2.4% concentration, prefilled in a 1.0 ml syringe. Manufactured by Becton Dickinson France S.A.S., France, or Schott Swiss AG, Switzerland – 2 units
Sterile rounded-tip hypodermic needle for hyaluronic acid administration, 30G x 13 mm (1/2"), manufactured by TSK Laboratory, Japan – 4 units
Instructions for use – 1 unit
Peel-off labels – 4 units

Repart® Supreme Medium

Intradermal implant, 1.0 ml volume, 2.4% concentration, prefilled in a 1.0 ml syringe. Manufactured by Becton Dickinson France S.A.S., France, or Schott Swiss AG, Switzerland – 2 units
Sterile rounded-tip hypodermic needle for hyaluronic acid administration, 27G x 13 mm (1/2"), manufactured by TSK Laboratory, Japan – 4 units
Instructions for use – 1 unit
Peel-off labels – 4 units

Repart® Supreme Hard

Intradermal implant, 1.0 ml volume, 2.4% concentration, prefilled in a 1.0 ml syringe. Manufactured by Becton Dickinson France S.A.S., France, or Schott Swiss AG, Switzerland – 2 units
Sterile rounded-tip hypodermic needle for hyaluronic acid administration, 27G x 13 mm (1/2"), manufactured by TSK Laboratory, Japan – 4 units
Instructions for use – 1 unit
Peel-off labels – 4 units

If your organization wants to sell medical equipment, medical products or medical consumables in Russia, for example, Repart® Supreme Intradermal Implant, then our information portal MEDCOMMERCE can help you with this. To do this, simply fill out the feedback form by clicking on the link FEEDBACK FORM.

The products posted on our website are approved for use in Russia by the state regulator Roszdravnadzor (Federal Service for Surveillance in Healthcare). The information is for informational purposes only.

Back